Johnson & JohnsonJNJ
Big pharma · NYSE · USA
Up 24.9% this year and +0.7% since June 26, behind the life science sector at +10.7%. Johnson & Johnson supplies 2 mapped companies and buys from 2.
Suppliers 2
Customers 2
About Johnson & Johnson
Two businesses under one name: Innovative Medicine, which covers immunology and oncology drugs, and MedTech, which makes medical devices and surgical equipment.
Theme exposure
Same segment: Big pharma
Large, diversified pharmaceutical groups with broad portfolios across therapeutic areas. Segment 2 of 8 in the Medicine, pharma & life science value chain.
Compare JNJ
Side by side with the largest companies in the same segment.
See where Johnson & Johnson sits in the full Medicine, pharma & life science map: every segment from upstream suppliers to end markets, with daily metrics.
Open the Life science value chain →